Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HUMANA INCHUM · Entity 1429 | President, Enterprise Growth | May 01, 2026 | May 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HUMANA INC
Report date May 01, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Humana CommonSEC Table I · non-derivative | Direct | 25,407 |
Reported balance
After 2026-05-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-01 · Grant · Acquired 11,273 · Balance 25,407 F2: Includes 18,617 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $367.21 · Expires 2031-02-21 | Direct | 51,389 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 51,389 F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
F2: Includes 18,617 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2026 Filed May 5, 2026 19:54 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 11,273 | $0.00 | $0.00 |
DisclosureSEC source: 0002010288-26-000004 · form4.xml · nonDerivative · entry 1 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,407 F2 · balance_after: Includes 18,617 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 16:24 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 1,182 | $189.66 | $224,172.21 |
DisclosureSEC source: 0002010288-26-000002 · form4.xml · nonDerivative · entry 2 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,134 F3 · shares: Shares disposed of represent payment for tax liability on restricted stock units vested on 2/21/26. F2 · balance_after: Includes 7,344 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 16:24 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 3,858 | $0.00 | $0.00 |
DisclosureSEC source: 0002010288-26-000002 · form4.xml · nonDerivative · entry 1 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 19:58 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 918 | $270.16 | $248,002.29 |
DisclosureSEC source: 0002010288-25-000003 · form4.xml · nonDerivative · entry 2 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,316 F3 · shares: Shares disposed of represent payment for tax liability on restricted stock units vested on 12/15/25. F2 · balance_after: Includes 11,202 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 19:58 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 2,032 | $0.00 | $0.00 |
DisclosureSEC source: 0002010288-25-000003 · form4.xml · nonDerivative · entry 1 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 20:11 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 4,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003420 · form4.xml · nonDerivative · entry 2 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,234 F2 · balance_after: Includes 13,234 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 20:11 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 1,175 | $258.58 | $303,825.63 |
DisclosureSEC source: 0001062993-25-003420 · form4.xml · nonDerivative · entry 1 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,874 F3 · shares: Shares disposed of represent payment for tax liability on restricted stock units vested on 2/21/25. Read SEC document |
| December 15, 2024 Filed Dec 17, 2024 16:50 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 261 | $271.68 | $70,907.18 |
DisclosureSEC source: 0001062993-24-020725 · form4.xml · nonDerivative · entry 1 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,049 F3 · shares: Shares disposed of represent payment for tax liability on restricted stock units vested on 12/15/24. F2 · balance_after: Includes 12,732 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 17:07 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 51,389 | $0.00 Strike: $367.21 | $0.00 |
DisclosureSEC source: 0001062993-24-004156 · form4.xml · derivative · entry 2 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,389 Underlying: Humana Common · 51,389 shares Expires 2031-02-21 F1 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. F1 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 17:07 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 13,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004156 · form4.xml · nonDerivative · entry 1 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,310 F2 · shares: Restricted stock units granted to reporting person on 2/21/24. F3 · balance_after: Includes 13,310 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.